Thermo Fisher Q2 Revenues Slip 1 Percent on Currency Effect | GenomeWeb

NEW YORK (GenomeWeb) – Thermo Fisher Scientific today reported a 1 percent decline in its second quarter revenues but still beat analysts' average estimate. 

For the three months ended June 27, the firm posted $4.27 billion in revenues, down from $4.32 billion from the year-ago quarter but above the consensus Wall Street estimate of $4.17 billion.

Thermo Fisher said that its organic revenue growth was 6 percent. The firm said that divestitures, net of acquisitions, decreased its revenue by 1 percent in the quarter and currency translation reduced revenue by 6 percent. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.